Serum homocysteine in pre-eclampsia and eclampsia

Area of Science:

• Obstetrics and Gynecology
• Clinical Chemistry
• Maternal-Fetal Medicine

Background:

• Pre-eclampsia and eclampsia are significant causes of adverse pregnancy outcomes.
• Hyperhomocysteinemia is increasingly recognized as a potential contributing factor to these conditions.

Purpose of the Study:

• To investigate the association between serum homocysteine levels and the incidence of pre-eclampsia and eclampsia.
• To provide insights for potential prevention strategies for these pregnancy complications.

Main Methods:

• A case-control study was conducted.
• Serum homocysteine levels were measured in three groups: healthy pregnant controls, pre-eclamptic women, and eclamptic women.

Main Results:

• Serum homocysteine levels were significantly elevated in both pre-eclamptic (9.54 ± 3.21 µmol/L) and eclamptic (10.57 ± 3.39 µmol/L) women compared to healthy controls (6.86 ± 2.47 µmol/L) (p < 0.001).
• Homocysteine levels were significantly higher in women with eclampsia than in those with pre-eclampsia (p < 0.03).

Conclusions:

• Hyperhomocysteinemia is strongly associated with both pre-eclampsia and eclampsia.
• The elevation in homocysteine is more pronounced in eclampsia, suggesting a potential link to disease severity.